News & Perspective

Aug 30, 2010

Aug 30, 2010

HHS funds development of drug for plague, tularemia

(CIDRAP News) – The US Department of Health and Human Services (HHS) has awarded a contract to a San Francisco company to further the development of a new broad-spectrum antibiotic for treating plague, tularemia, and various resistant infections.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»